top of page

Reply to: Utility of Progression Rate Since Symptom Onset in Predicting Subsequent Survival in Progressive Supranuclear Palsy

​

Quattrone A, Franzmeier N, Hoglinger GU.

Mov Disord. 2025 Nov 17. doi: 10.1002/mds.70124. Online ahead of print.

2025

PMID

41243832

https://doi.org/10.1002/mds.70124

PSP

​

​

Reply to: Utility of Progression Rate Since Symptom Onset in Predicting Subsequent Survival in Progressive Supranuclear Palsy
bottom of page